These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25368239)

  • 1. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.
    Masuda T; Nakashima Y; Ando K; Yoshinaga K; Saeki H; Oki E; Morita M; Oda Y; Maehara Y
    Anticancer Res; 2014 Nov; 34(11):6397-403. PubMed ID: 25368239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis.
    Tsuboi K; Kodera Y; Nakanishi H; Ito S; Mochizuki Y; Nakayama G; Koike M; Fujiwara M; Yamamura Y; Nakao A
    Oncol Rep; 2008 Nov; 20(5):1117-23. PubMed ID: 18949410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implication of CXCL12 expression in gastric cancer.
    Ishigami S; Natsugoe S; Okumura H; Matsumoto M; Nakajo A; Uenosono Y; Arigami T; Uchikado Y; Setoyama T; Arima H; Hokita S; Aikou T
    Ann Surg Oncol; 2007 Nov; 14(11):3154-8. PubMed ID: 17653799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can expression of CXCL12 and CXCR4 be used to predict survival of gastric cancer patients?
    Satomura H; Sasaki K; Nakajima M; Yamaguchi S; Onodera S; Otsuka K; Takahashi M; Muroi H; Shida Y; Ogata H; Okamoto K; Kato H
    Anticancer Res; 2014 Aug; 34(8):4051-7. PubMed ID: 25075029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
    Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
    Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
    van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.
    Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Okugawa Y; Kawamoto A; Yasuda H; Inoue Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2010 Aug; 17(8):2051-8. PubMed ID: 20177796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis.
    Noda S; Yashiro M; Toyokawa T; Morimoto J; Shinto O; Muguruma K; Sawada T; Hirakawa K
    Ann Surg Oncol; 2011 Dec; 18(13):3718-25. PubMed ID: 21573834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
    Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
    Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
    Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glasgow prognostic score is a useful predictive factor of outcome after palliative gastrectomy for stage IV gastric cancer.
    Mimatsu K; Oida T; Fukino N; Kano H; Kawasaki A; Kida K; Kuboi Y; Amano S
    Anticancer Res; 2014 Jun; 34(6):3131-6. PubMed ID: 24922683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.
    Stanisavljević L; Aßmus J; Storli KE; Leh SM; Dahl O; Myklebust MP
    Tumour Biol; 2016 Jun; 37(6):7441-52. PubMed ID: 26678887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
    Fanelli MF; Chinen LT; Begnami MD; Costa WL; Fregnami JH; Soares FA; Montagnini AL
    Histopathology; 2012 Aug; 61(2):153-61. PubMed ID: 22582975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
    Woo SU; Bae JW; Kim CH; Lee JB; Koo BW
    Ann Surg Oncol; 2008 Jan; 15(1):281-5. PubMed ID: 17763975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
    Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
    Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
    Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
    Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.
    Yopp AC; Shia J; Butte JM; Allen PJ; Fong Y; Jarnagin WR; DeMatteo RP; D'Angelica MI
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S339-46. PubMed ID: 21584832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis.
    Iwasa S; Yanagawa T; Fan J; Katoh R
    Anticancer Res; 2009 Nov; 29(11):4751-8. PubMed ID: 20032431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of gastric cancer with concomitant liver metastases.
    Kwok CM; Wu CW; Lo SS; Shen KH; Hsieh MC; Lui WY
    Hepatogastroenterology; 2004; 51(59):1527-30. PubMed ID: 15362793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.